Blood Platelet Market Size, Share, Competitive Landscape and Trend Analysis Report, by Platelet Type, by Application, by End User : Global Opportunity Analysis and Industry Forecast, 2024-2033

Key Market Dynamics

The increasing demand of platelet-rich plasma (PRP) therapies is significantly driving the growth of the blood platelets market. PRP, which is derived from a patient’s own blood, contains high concentrations of platelets, cytokines, and growth factors. These components are known for their regenerative and healing properties, making PRP therapies increasingly adopted in various medical and aesthetic fields. The effectiveness of PRP in promoting tissue repair and reducing inflammation has contributed to its widespread adoption, highlighting its vital role in the expanding blood platelets market.

However, despite stringent screening, platelet collection, storage, and transfusion remain susceptible to bacterial contamination, endangering patients. This hinders platelet growth efforts, exacerbating healthcare challenges. Vigilance in handling and processing is imperative to mitigate these risks and ensure safe transfusion practices, safeguarding patient health and well-being.

Moreover, the advancing landscape of healthcare, personalized medicine and regenerative therapies are expected to revolutionize the augmentation of blood platelet growth in the upcoming years. Leveraging advanced treatments and innovative regenerative techniques, the medical community anticipates a surge in the optimization of platelet production, addressing various health conditions with greater precision and efficacy. This increasing demand signifies a paradigm shift towards individualized care, harnessing the power of innovative technology and scientific breakthroughs to enhance patient outcomes. As research continues to increase, the integration of personalized medicine and regenerative therapies promises a transformative journey in the field of hematology and beyond.

Analysis of Blood Donors in Major Economies

The number of blood donors is rising globally, driven by increasing awareness among people about the importance of blood donation. This growing awareness is largely due to intensified educational campaigns that highlight the critical role of blood donations in saving lives. Governments worldwide are also implementing a range of initiatives to boost donor numbers, aiming to meet the escalating demand for blood required for critically ill patients. These initiatives include organizing blood donation drives, offering incentives to donors, and improving the infrastructure and accessibility of blood donation centers. Such measures are essential in ensuring a stable and sufficient blood supply, which is crucial for medical emergencies, surgeries, and the treatment of various diseases. As a result, the combined efforts of public awareness and governmental support are significantly contributing to the upward trend in blood donations, helping to bridge the gap between supply and demand in healthcare systems worldwide. This positive development is vital for enhancing the ability of medical facilities to provide timely and effective care to patients in need.

Important Insights According to WHO 2023 Publication

Important Insights According to WHO 2023 Publication

Of the 118.5 million global blood donations, 40% are collected in high-income countries, which constitute only 16% of the world's population. This highlights a significant disparity in blood donation distribution between high-income and other countries.

In low-income countries, up to 54% of blood transfusions are administered to children under five, while in high-income countries, the most frequently transfused group is those over 60, accounting for up to 76% of all transfusions. This highlights significant disparities in blood transfusion demographics across different income levels.

Blood donation rates vary significantly across income levels. High-income countries exhibit the highest rate, with 31.5 donations per 1000 people, followed by upper-middle-income countries at 16.4. Lower-middle-income and low-income countries have substantially lower rates, at 6.6 and 5.0 donations respectively.

The volume of plasma available for fractionation per 1000 population differs greatly across 45 reporting countries, spanning from 0.1 to 52.6 litres, with a median of 5.2 litres. This vast range underscores significant disparities in plasma accessibility and distribution among nations worldwide.

Source : WHO, AMR Analysis, Secondary Research

Market Segmentation

The blood platelet market is segmented into platelet type, application, end user, and region. On the basis of platelet type, the market is divided into whole blood derived platelets, and apheresis derived platelets. As per application, the market is segregated into platelet function disorder, hemophilia, thrombocytopenia, and perioperative indication. On the basis of end user the market is diverged into hospitals, ambulatory surgical centers, blood banks, research laboratories, specialty clinics, cancer treatment centers, trauma centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Regional Market Outlook

The demand for blood platelets has seen a significant surge, with North America holding the dominant share in 2023. This region has emerged as a dominant force in driving the need for platelet donations, reflecting a combination of factors such as increasing medical procedures requiring platelets, rising instances of diseases like cancer that necessitate platelet transfusions, and a growing awareness among the populace regarding the importance of blood donations. North America's advanced healthcare infrastructure, coupled with advanced medical technologies and a proactive approach towards addressing health concerns, has further fueled this demand. Additionally, proactive initiatives by healthcare organizations and government agencies to encourage blood donations have contributed to the heightened demand for platelets. For instance, in September 2023, AABB (Association for the Advancement of Blood & Biotherapies) agreed to work with a range of medical professionals, industry partners, blood collectors, and government agencies to establish the Prehospital Blood Transfusion Initiative Coalition (PHBTIC) . This collaborative effort aims to broaden access to prehospital blood transfusions, combining diverse expertise for improved emergency medical care delivery.

In February 2024, America’s Blood Centers (ABC) unveiled its 2024 Advocacy Agenda, defining federal legislative and regulatory priorities crucial for community blood centers. Shaped in consultation with the ABC Board of Directors, Policy Council, and member blood centers, the agenda emphasizes legislative and regulatory solutions. It serves as a blueprint for ABC's advocacy efforts, aimed at highlighting the significance of blood for patients, communities, and the healthcare system. ABC attempts to collaborate with the Administration, Congress, and industry stakeholders to elevate awareness and promote the role of blood donation in sustaining health and saving lives.

Competitive Landscape

The major players operating in the blood platelet market include America’s Blood Centers, American Association of Blood Banks (AABB) , Canadian Blood Services, French Red Cross, European Blood Alliance, Japanese Red Cross Society, American National Red Cross, OneBlood, Australian Red Cross, and Blood Bank of Alaska. Other players in the blood platelet market include Indian Red Cross Society, and Brazilian Red Cross.

Recent Key Strategies and Developments

• In January 2023, Defense Advanced Research Projects Agency (DARPA) allocated $46 million to a coalition of universities and biotech firms to pioneer a shelf-stable whole blood alternative for emergency trauma care. This initiative, under DARPA's Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program, aims to address critical scenarios where traditional blood products are unavailable during trauma incidents or transportation. The consortium, comprising over a dozen institutions, will focus on creating a viable substitute that can effectively resuscitate patients in urgent situations.

Industry Trends

• In August 2023, Helmer Scientific introduced the pro line floor model platelet storage systems, which combine advancements in performance, reliability, and efficiency to ensure optimal platelet storage and compliance with blood bank standards. These incubators are equipped with OptiCool RT cooling and heating technology, which integrates a variable capacity compressor (VCC) and natural hydrocarbon (HC) refrigerants with pulse heating. This innovative system offers a dependable storage solution, ensuring the safe preservation of platelet products.

• In February 2023, Terumo Blood and Cell Technologies received U.S. Food and Drug Administration (FDA) clearance for its IMUGARD WB Platelet Pooling Set, which marks the official launch of this innovative product. The IMUGARD set is the first in the U.S. to be approved for extending the shelf life of whole blood-derived platelets from five days to seven days. This advancement offers a critical alternative source of platelet supply, addressing the growing demand amid a persistent shortage of blood donors. By enhancing the longevity of platelet storage, IMUGARD is expected to improve supply challenges and ensure a more reliable availability of these vital blood components. This FDA approval highlights a significant step forward in blood management and transfusion practices, providing healthcare facilities with a more efficient and extended-use option for platelet storage.

Key Sources Referred

1. America’s Blood Centers
2. American Association of Blood Banks (AABB)
3. French Red Cross
4. European Blood Alliance
5. Helmer Scientific

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the blood platelet market analysis from 2024 to 2033 to identify the prevailing blood platelet market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the blood platelet market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global blood platelet market trends, key players, market segments, application areas, and market growth strategies.